Tower Research Capital (TRC)’s Zentalis Pharmaceuticals ZNTL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $19.9K | Buy |
17,114
+11,873
| +227% | +$13.8K | ﹤0.01% | 3686 |
|
|
2025
Q1 | $8.33K | Sell |
5,241
-3,394
| -39% | -$5.4K | ﹤0.01% | 3901 |
|
|
2024
Q4 | $26.2K | Buy |
8,635
+686
| +9% | +$2.08K | ﹤0.01% | 2980 |
|
|
2024
Q3 | $29.3K | Sell |
7,949
-29,536
| -79% | -$109K | ﹤0.01% | 3017 |
|
|
2024
Q2 | $153K | Buy |
37,485
+37,421
| +58,470% | +$153K | ﹤0.01% | 2269 |
|
|
2024
Q1 | $1.01K | Sell |
64
-3,551
| -98% | -$56K | ﹤0.01% | 5347 |
|
|
2023
Q4 | $54.8K | Buy |
3,615
+2,589
| +252% | +$39.2K | ﹤0.01% | 3069 |
|
|
2023
Q3 | $20.6K | Sell |
1,026
-5,894
| -85% | -$118K | ﹤0.01% | 3345 |
|
|
2023
Q2 | $195K | Buy |
6,920
+4,829
| +231% | +$136K | 0.01% | 1560 |
|
|
2023
Q1 | $36K | Sell |
2,091
-487
| -19% | -$8.39K | ﹤0.01% | 2821 |
|
|
2022
Q4 | $51K | Sell |
2,578
-3,443
| -57% | -$68.1K | ﹤0.01% | 2341 |
|
|
2022
Q3 | $130K | Sell |
6,021
-1,619
| -21% | -$35K | ﹤0.01% | 2326 |
|
|
2022
Q2 | $215K | Buy |
7,640
+7,122
| +1,375% | +$200K | ﹤0.01% | 1719 |
|
|
2022
Q1 | $24K | Sell |
518
-3,424
| -87% | -$159K | ﹤0.01% | 3381 |
|
|
2021
Q4 | $331K | Buy |
3,942
+1,325
| +51% | +$111K | 0.01% | 1409 |
|
|
2021
Q3 | $175K | Sell |
2,617
-467
| -15% | -$31.2K | ﹤0.01% | 1941 |
|
|
2021
Q2 | $164K | Buy |
3,084
+1,640
| +114% | +$87.2K | ﹤0.01% | 2072 |
|
|
2021
Q1 | $63K | Buy |
1,444
+726
| +101% | +$31.7K | ﹤0.01% | 2935 |
|
|
2020
Q4 | $37K | Sell |
718
-8,516
| -92% | -$439K | ﹤0.01% | 3404 |
|
|
2020
Q3 | $302K | Buy |
9,234
+8,724
| +1,711% | +$285K | ﹤0.01% | 2184 |
|
|
2020
Q2 | $24K | Buy |
+510
| New | +$24K | ﹤0.01% | 3594 |
|